http://www.anjarium.com/  

8952 Schlieren, Wagistrasse 23

 +41 44 552 38 88
 info@anjarium.com

Anjarium Biosciences AG is a genetic medicines company focused on creating and delivering a new generation of targeted gene therapies to patients. Anjarium’s versatile platform builds on novel therapeutic payloads and delivery technologies, with the aim to unlock the full potential of gene therapy.

https://www.athebio.com/  

8952 Schlieren, Grabenstrasse 11a

  +41 44 508 08 28
 hello@athebio.com

Athebio develops advanced binding molecules based on repeat proteins to help drug developers fill their pipelines with innovative drug candidates.

http://www.bio-technopark.ch/  

8952 Schlieren, Wagistrasse 23

 +41 76 336 99 44
 mario.jenni@bio-technopark.ch

The Bio-Technopark offers professional support for life science start-ups in the setting up and expansion of business activities and promotes interaction between start-ups, academia and industry. A nationally and internationally respected science park has grown up at Schlieren. Through stringent selection, coaching and support, more than 30 successful start-up companies with 750 employees are located here. Eight have been acquired by large corporates, but are still active in the park. Together with 20 institutes and clinics from the University and University Hospital Zurich, an innovative mix of very young and well-established companies and academic research groups has emerged.

http://www.biognosys.ch/  

8952 Schlieren, Wagistrasse 25

 +41 44 738 20 40
 info@biognosys.ch

BiognoSYS provides proteomics solutions to scientists and clinicians.

http://cdr-life.com/  

8952 Schlieren, Wagistrasse 14

 konstantin.vonschulthess@cdr-life.com

CDR-Life is a Zurich-based biotech company that discovers and develops innovative medicines for the treatment of high need diseases. We invent and develop therapeutic antibody fragments with a focus on immuno-oncology and ophthalmology.

http://www.cellerys.com/  

8952 Schlieren, Wagistrasse 21

Cellerys is a spin-off from University Hospital and University of Zurich. The company develops new therapies against Multiple Sclerosis (MS).

http://www.crystallise.ch  

8952 Schlieren, Grabenstrasse 11a

 +41 44 558 34 00
 info@crystallise.ch

Crystallise! operates an independent lab for crystallographic services (X-ray diffraction of single crystals) focussing on identifications of small molecule substances including air/moisture/temperature sensitive compounds and unique analyses of liquids.

http://cutiss.swiss  

8952 Schlieren, Grabenstrasse 11

 +41 44 244 36 60
 info@cutiss.swiss

After more than 15 years of research (Tissue Biology Research Unit, University Children’s Hospital Zurich), CUTISS AG can now bio-engineer large quantities of individually customized human skin grafts, denovoSkin™, starting off from a very small piece of healthy patient’s skin. Because of its intrinsic characteristics, denovoSkin™ is expected to result in a minimally scarring outcome after transplantation. denovoSkin™ received a Swissmedic, EMA and FDA Orphan drug designation for the treatment of burns.

https://dinaqor.com/  

8952 Schlieren, Wagistrasse 25

DiNAQOR’s mission is to develop gene therapy solutions that transform the lives of patients with heart disease. Our novel and innovative gene therapy platform is focused on advancing treatments for patients affected by genetic cardiomyopathies, a disease of the heart muscle that can lead to heart failure.

https://dinamiqs.com/  

8952 Schlieren, Wagistrasse 25

DiNAQOR DiNAMIQS provides a comprehensive range of manufacturing services, process development, quality control and analytics solutions to support and accelerate your gene therapy project.